vs
Acadia Healthcare Company, Inc.（ACHC）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是UiPath, Inc.的2.0倍（$829.0M vs $411.1M），UiPath, Inc.净利率更高（48.4% vs 0.5%，领先47.8%），UiPath, Inc.同比增速更快（15.9% vs 7.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs 0.7%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
ACHC vs PATH — 直观对比
营收规模更大
ACHC
是对方的2.0倍
$411.1M
营收增速更快
PATH
高出8.4%
7.5%
净利率更高
PATH
高出47.8%
0.5%
两年增速更快
ACHC
近两年复合增速
0.7%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $411.1M |
| 净利润 | $4.5M | $198.8M |
| 毛利率 | — | 83.3% |
| 营业利润率 | — | 3.2% |
| 净利率 | 0.5% | 48.4% |
| 营收同比 | 7.5% | 15.9% |
| 净利润同比 | -50.8% | 1966.2% |
| 每股收益（稀释后） | $0.05 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCPATH
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $411.1M | ||
| Q3 25 | $851.6M | $361.7M | ||
| Q2 25 | $869.2M | $356.6M | ||
| Q1 25 | $770.5M | $423.6M | ||
| Q4 24 | $774.2M | $354.7M | ||
| Q3 24 | $815.6M | $316.3M | ||
| Q2 24 | $796.0M | $335.1M |
净利润ACHCPATH
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $198.8M | ||
| Q3 25 | $36.2M | $1.6M | ||
| Q2 25 | $30.1M | $-22.6M | ||
| Q1 25 | $8.4M | $51.8M | ||
| Q4 24 | $32.6M | $-10.7M | ||
| Q3 24 | $68.1M | $-86.1M | ||
| Q2 24 | $78.5M | $-28.7M |
毛利率ACHCPATH
| Q1 26 | — | — | ||
| Q4 25 | — | 83.3% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | — | 84.8% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 83.5% |
营业利润率ACHCPATH
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 3.2% | ||
| Q3 25 | 4.7% | -5.6% | ||
| Q2 25 | 5.8% | -4.6% | ||
| Q1 25 | 1.7% | 7.9% | ||
| Q4 24 | 4.9% | -12.2% | ||
| Q3 24 | 12.1% | -32.7% | ||
| Q2 24 | 13.4% | -14.8% |
净利率ACHCPATH
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 48.4% | ||
| Q3 25 | 4.3% | 0.4% | ||
| Q2 25 | 3.5% | -6.3% | ||
| Q1 25 | 1.1% | 12.2% | ||
| Q4 24 | 4.2% | -3.0% | ||
| Q3 24 | 8.4% | -27.2% | ||
| Q2 24 | 9.9% | -8.6% |
每股收益（稀释后）ACHCPATH
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.37 | ||
| Q3 25 | $0.40 | $0.00 | ||
| Q2 25 | $0.33 | $-0.04 | ||
| Q1 25 | $0.09 | $0.09 | ||
| Q4 24 | $0.36 | $-0.02 | ||
| Q3 24 | $0.74 | $-0.15 | ||
| Q2 24 | $0.85 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $1.4B |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $1.9B |
| 总资产 | $5.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCPATH
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $1.4B | ||
| Q3 25 | $118.7M | $1.4B | ||
| Q2 25 | $131.4M | $1.6B | ||
| Q1 25 | $91.2M | $1.6B | ||
| Q4 24 | $76.3M | $1.6B | ||
| Q3 24 | $82.1M | $1.7B | ||
| Q2 24 | $77.2M | $1.9B |
总债务ACHCPATH
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCPATH
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.9B | ||
| Q3 25 | $3.1B | $1.7B | ||
| Q2 25 | $3.1B | $1.7B | ||
| Q1 25 | $3.0B | $1.8B | ||
| Q4 24 | $3.1B | $1.7B | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | $2.0B |
总资产ACHCPATH
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.9B | ||
| Q3 25 | $6.4B | $2.6B | ||
| Q2 25 | $6.3B | $2.6B | ||
| Q1 25 | $6.1B | $2.9B | ||
| Q4 24 | $6.0B | $2.7B | ||
| Q3 24 | $5.9B | $2.7B | ||
| Q2 24 | $5.7B | $2.8B |
负债/权益比ACHCPATH
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | — | $25.1M |
| 自由现金流率自由现金流/营收 | — | 6.1% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | 13.78× | 0.14× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCPATH
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $28.3M | ||
| Q3 25 | $73.2M | $41.6M | ||
| Q2 25 | $133.5M | $119.0M | ||
| Q1 25 | $11.5M | $146.1M | ||
| Q4 24 | $116.7M | $28.1M | ||
| Q3 24 | $163.1M | $46.4M | ||
| Q2 24 | $171.1M | $100.0M |
自由现金流ACHCPATH
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $25.1M | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | $106.2M | ||
| Q1 25 | $-163.2M | $138.7M | ||
| Q4 24 | $-86.8M | $23.2M | ||
| Q3 24 | $-27.1M | $45.0M | ||
| Q2 24 | $16.9M | $98.8M |
自由现金流率ACHCPATH
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 6.1% | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | 29.8% | ||
| Q1 25 | -21.2% | 32.7% | ||
| Q4 24 | -11.2% | 6.5% | ||
| Q3 24 | -3.3% | 14.2% | ||
| Q2 24 | 2.1% | 29.5% |
资本支出强度ACHCPATH
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.8% | ||
| Q3 25 | 16.0% | 0.0% | ||
| Q2 25 | 19.3% | 3.6% | ||
| Q1 25 | 22.7% | 1.7% | ||
| Q4 24 | 26.3% | 1.4% | ||
| Q3 24 | 23.3% | 0.4% | ||
| Q2 24 | 19.4% | 0.4% |
现金转化率ACHCPATH
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | 2.02× | 26.25× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 2.82× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
